An investor, who purchased shares of Akero Therapeutics, Inc. (NASDAQ: AKRO), filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Fe… Read More

Introduction Fatty liver disease & Bariatric Surgery: Fatty liver disease, especially Non-Alcoholic Fatty Liver Disease (NAFLD), is often linked with being… Read More

Intermittent fasting, particularly the 5:2 regime, emerges as a potent ally in the fight against liver cancer and inflammation. Studies reveal that key proteins play a pivotal role in the pr… Read More

In 2023, the US Food and Drug Administration (FDA) approved a record-breaking 61 drugs, the most in history. While it isn’t known whether 2024 might beat that record, it will surely be… Read More

Introduction In a landscape where many contract research organizations (CROs) are available, Vial is breaking through with its promise to deliver on its vision to empower scientists to cu… Read More

Fatty liver disease, also known as hepatic steatosis, is a condition characterized by the accumulation of fat in the liver cells. This buildup of fat can lead to liver inflammation and damag… Read More

Estimated reading time: 0 minutes The escalating global epidemic of obesity brings to light its extensive health repercussions, especially its profound influence on liver function. This… Read More

If there’s one thing that can quickly send a healthcare stock soaring, it’s the approval of a key drug. Not only can that give investors confidence in a business’s abil… Read More

Estimated reading time: 0 minutes The growing epidemic of obesity has significant implications for liver health, marking a critical concern in public health. This complex interplay betwe… Read More

Context: Madrigal Pharmaceuticals Inc.’s drug Rezdiffra gained the first US approval to treat a potentially deadly liver disease called nonalcoholic steatohepatitis, or NASH that affec… Read More

What matters in science |  View this email in your browser Monday 18 March 2024… Read More

(CTN News) – The FDA’s first approved drug for treating liver scarring caused by common diseases is now available to millions of Americans, the Federal Drug Administration announ… Read More

In the face of rising obesity rates, nonalcoholic fatty liver disease (NAFLD) has emerged as a silent epidemic, affecting millions worldwide. This chronic condition, characterized by the acc… Read More

With the rising prevalence of metabolic disorders, the rapid emergence of various types of novel therapeutic agents has been the need of hour. Amongst all the recently available anti-obesit… Read More

Wilmington, Delaware, United States, 2024-Mar-01 — /EPR Network/ — Nonalcoholic steatohepatitis (NASH) represents a significant and growing public health concern worldwide, chara… Read More

The global Non-Alcoholic Steatohepatitis (NASH) market size was USD 2.42 billion in 2022 and is expected to reach USD 13.45 billion in 2032 Read More

Losing weight with fatty liver, is it possible? Maintaining a healthy weight is important for overall health, and it is particularly important for liver health. The liver is a vital organ re… Read More

Recently, Eli Lilly revealed promising results from a mid-stage trial, indicating that its popular drug, tirzepatide (marketed as Zepbound and Mounjaro for weight loss and diabetes, respec… Read More

A recent study by the All India Institute of Medical Sciences (AIIMS) has highlighted a concerning trend: 38% of the population is grappling with non-alcoholic fatty liver disease (NAFLD)… Read More

IntroductionBelly fat, also known as visceral fat, is not merely an aesthetic concern but a significant health risk. Its accumulation around the abdomen can have far-reaching consequences on… Read More

What Are The Symptoms Of Fatty Liver Disease In Humans – Non-Alcoholic Fatty Liver Disease (NAFLD) is a common and worrying health condition that affects millions of people worldwide… Read More

There are many foods that are high in zinc, which is an essential mineral for good health and metabolism. (CREDIT: AI generated - Microsoft Image Creator)In a groundbreaking study, a major l… Read More

Fatty liver disease, encompassing nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic steatohepatitis (NASH), has emerged as a prevalent health concern in modern… Read More

Metabolic dysfunction-associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults af… Read More

Liver disease is often a silent killer and can advance unseen until it reaches advanced stages, making effective treatment challenging. Condit… Read More

Fatty liver disease, also known as hepatic steatosis, is a condition characterized by the accumulation of excess fat in the liver. Excessive fat accumulation (steatosis) in the liver (> 5… Read More

The ADVANCE (Accelerating Discovery: Actionable NASH Cirrhosis Endpoints) study will follow 200 patients with cirrhosis – scarring caused by long-term damage of the liver – to un… Read More

Inhalable sensors could enable early lung cancer detection. The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible w… Read More

Semaglutide, your innovative relief medication around the treatment of style couple of diabetes plus overweight, includes received sizeable particular attention while in the health sphere. F… Read More

Hepatitis definitionHepatitis is a medical term that refers to inflammation of the liver. It can be caused by various factors, including viral infections, autoimmune diseases, metabolic diso… Read More

[Dec. 29, 2023: JJ Shavit, The Brighter Side of News] Academics and experts have acclaimed this investigation as a pivotal one that considerably enhances our grasp over zinc's involvement i… Read More

Eli Lily and Novo Nordisk, two pharmaceutical giants in the diabetes and obesity treatment market, have recently revealed their ambitious plans to expand their offerings to include comprehen… Read More

What is Semaglutide Peptide? Similar to the naturally occurring hormone glucagon-like peptide-1 (GLP-1), Semaglutide peptide is an artificial 31-amino-acid polypeptide that belongs to the f… Read More

Stocks have rallied this week, with the major averages headed for their seventh straight week in the green, and investors are betting this momentum will continue moving forward. The S &am… Read More

As the world grapples with the consequences of poor dietary habits and sedentary lifestyles, the need for effective treatments has never been greater. Fatty liver disease has emerged as a w… Read More

[Nov. 17, 2023: Staff Writer, The Brighter Side of News] Nonalcoholic steatohepatitis, the severe form of NAFLD, can cause irreversible liver damage and affects 6.5% of the global populati… Read More

Fatigue & weakness, jaundice, abdominal discomfort are some symptoms of fatty liver. Liver plays an important role in various metabolic functions including filtering blood, detoxifica… Read More

What Is The Cause Of Enlarged Liver – The liver usually contains some fat, but excess fat accumulation can cause fatty liver disease. Fatty liver disease can reduce liver function and… Read More